Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,532.7
17.0 (0.68%)

 

  • STI Straits Times Index
    2,532.7
    17.0 (0.68%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,568.1
    -7.8 (-0.50%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,102.5
    155.9 (0.62%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,377.6
    5.9 (0.17%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,514.8
    -58.8 (-0.26%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,127.1
    52.0 (1.03%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,493.1M
  • Value: 1,391.4M
  • Rise: 221
  • Fall: 111
  • Unch: 476

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.186+0.003
Leader Env0.064+0.008
AnAn Intl0.043+0.008
Synagie0.194+0.005
LionGold0.002-
Genting Sing0.710-0.020
Medtecs Intl1.010+0.025
ISDN0.370+0.070
CNMC Goldmine0.355+0.045
Anchor Resources0.009+0.002

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MERRIMACK PHARMACEUTICALS INC MERRIMACK PHARMACEUTICALS
Updated on 04 Aug 2020 (End of trading day)
Last (USD): 3.410 Change: -0.180 High: 3.640 Remarks: -
Change (%): -5.01 Low: 3.350
Open 3.620 Yesterday's Close 3.5900000000000003
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 32,835 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.58944 Trailing EPS (USD) e -0.78923 NAV (USD) b 1.3486
PE a - Trailing PE f - Price / NAV b 2.5285
Dividend (USD) d 0.500731 Cash In Hand (USD) g 1.3471 Issued & Paid-up Shares c 13,380,200
Dividend Yield (%) d 14.684 Price / Cash In Hand g 2.531 Treasury Shares h -
Market Cap (M) 45.626 Enterprise Value (M) 27.601
Piotroski F Score 2 Exchange Code MACK Par Value ( $ ) n.a.
52 Weeks Volatility (%) 84.27 Free Float (%) 98.2
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 24 Apr 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MERRIMACK PHARMACEUTICALS INC NASDAQ 45.626 - - 2.5285 14.684
Industry Biotechnology NASDAQ 2,939.436 446.208 6455.431 7.2388 0.642
Local Peer AMGEN INC NASDAQ 142,669.201 18.193 19.546 13.3849 2.404
Local Peer GILEAD SCIENCES INC NASDAQ 88,909.746 16.508 - 4.9008 3.588
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 72,962.621 34.485 32.011 6.0136 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 71,813.357 61.024 34.355 9.5506 -
Local Peer ILLUMINA INC NASDAQ 57,870.960 57.755 61.434 12.4856 -
Local Peer BIOGEN INC NASDAQ 43,707.053 7.422 7.374 3.8649 -
Local Peer MODERNA INC NASDAQ 30,507.131 - - 18.5920 -
Local Peer SEATTLE GENETICS INC NASDAQ 28,721.685 - - 15.8327 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,061.383 9.592 27.256 2.1982 -
Local Peer INCYTE CORPORATION NASDAQ 21,726.431 48.615 - - -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 21,669.698 - 190.075 6.6882 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 19,895.292 - - 7.0747 -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), NOVAVAX INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), FATE THERAPEUTICS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), INSMED INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), VIELA BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), UNIQURE N.V. (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), XENCOR INC (NASDAQ), VAXCYTE INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), VERACYTE INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), MACROGENICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), REGENXBIO INC (NASDAQ), EPIZYME INC (NASDAQ), CORTEXYME INC (NASDAQ), ARVINAS INC (NASDAQ), ALECTOR INC (NASDAQ), NANTKWEST INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), TRANSLATE BIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), RETROPHIN INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), PASSAGE BIO INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), IMMATICS N V (NASDAQ), IMMUNOGEN INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), PERSONALIS INC (NASDAQ), AKOUOS INC (NASDAQ), VAXART INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AVROBIO INC (NASDAQ), AGENUS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), XBIOTECH INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), KAMADA (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), MERUS B V (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), IVERIC BIO INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), SERES THERAPEUTICS (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMV INC (NASDAQ), TREVENA INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AFFIMED N V (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), NEXTCURE INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CHIASMA INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), VERASTEM INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CABALETTA BIO INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), XOMA CORP (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), INMUNE BIO INC (NASDAQ), EQUILLIUM INC (NASDAQ), OTONOMY INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), INFLARX N V (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ORGENESIS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SESEN BIO INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), VACCINEX INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SAVARA INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), RESTORBIO INC (NASDAQ), ARAVIVE INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), OCUGEN INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), COHBAR INC (NASDAQ), CURIS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), PRECIPIO INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ATYR PHARMA INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ADVAXIS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), EVOGENE LTD (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer CSL ASX 126,293.729 47.073 43.598 14.6031 0.954
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer WUXI BIO HKEx 231,824.509 201.662 201.662 16.2109 -
Global Peer SINO BIOPHARM HKEx 188,159.822 61.305 61.866 5.4309 0.533
Global Peer BEIGENE HKEx 156,696.475 - - 7.1888 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 6,490.180 119.086 38.110 5.4139 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 31,664.246 - - 10.6156 -
Global Peer 3SBIO HKEx 24,875.919 22.530 22.530 2.3105 -
Global Peer HAOHAI BIOTEC HKEx 23,539.204 55.988 55.988 4.0021 0.579
Other Global Peers VIVA BIOTECH (HKEx), ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), ASCENTAGE-B (HKEx), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), KINTOR PHARMA-B (HKEx), KADMON HLDGS INC (NYSE), DPHARMA (Bursa), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), SINOMAB BIO-B (HKEx), IBIO INC (NYSE American), NANOVIRICIDES INC (NYSE American), ESSEX BIO-TECH (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TELIX PHARMACEUTIC (ASX), IMUGENE LIMITED (ASX), PFENEX INC (NYSE American), NEXT SCIENCE LTD (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), ENZO BIOCHEM INC (NYSE), CEL-SCI CORP (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), SYNTHETIC BIOLOGICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), IMMUTEP LTD (ASX), ANTEOTECH LIMITED (ASX), MEMPHASYS LTD (ASX), GENETIC TECHNOLOGIES (ASX), ORAGENICS INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), BIOTRON (ASX), INVEX THERAPEUTICS LTD NPV (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), CT ENTERPRISE (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), BIOSINO BIO-TEC (HKEx), BIONOMICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), REGENEUS LTD (ASX), Suntar Eco-City (SGX), NOVABAY PHARMACEUTICALS INC (NYSE American), REGENT PACIFIC (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), PATRYS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), ADALTA LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), HAO WEN H-NEW (HKEx), HAO WEN H-OLD (HKEx), FACTOR THERAPEUTICS LIMITED (ASX), NANOLLOSE LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.190
+5.90 %
10 Days -+0.140
+4.28 %
20 Days --0.080
-2.29 %
Medium Term Return 3 Months --0.470
-12.11 %
6 Months -+0.190
+5.90 %
1 Year 1.497-1.324
+3.65 %
Long Term Return 2 Years 1.497-0.352
+30.44 %
3 Years 1.497-5.400
-44.30 %
5 Years 2.552-46.532
-88.06 %
Annualised Return Annualised --
-34.63 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.490 - 5.505 Change From 1 Year Low +1.920 % Change From 1 Year Low (%) +128.86
Change From 1 Year High -2.095 % Change From 1 Year High (%) -38.06
2 Years Range 1.490 - 5.505 Change From 2 Years Low +1.920 % Change From 2 Years Low (%) +128.86
Change From 2 Years High -2.095 % Change From 2 Years High (%) -38.06
5 Years Range 1.490 - 53.176 Change From 5 Years Low +1.920 % Change From 5 Years Low (%) +128.86
Change From 5 Years High -49.766 % Change From 5 Years High (%) -93.59
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.